Dr. D Sleep Strips
Natural health product licensed in Canada
- Licence holder
- Promedx Innovations Inc.
- NPN or DIN-HM
- 80105370
- Status
- Active licence
- Licence date
- 16 October 2020
- Revision date
- Not provided
- Form
- Pellicule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Valeriana officinalis Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 30 mg Potency : 0.8 % Valerenic acid | 1.5 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1.5 mg | Not calculated |
Non-medicinal ingredients
Menthol, Sucralose, Triglycéride caprylique/caprique, Phosphatidylcholine, Huile de Palme, bêta Cyclodextrin, Piperine, Glycérine, Acacia, bêta-Myrcène, Oléate de glycéryle, Poly(sorbate) 80, Pullulane, Alginate de sodium, Sorbitol, Amidon de maïs
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Pellicule | 1 Tous les jours |
Uses authorised in Canada
Helps re-set the body's sleep-wake cycle (aspect of the circadian rhythm) and increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule (e.g. shift work and jet lag).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Stop use if allergy occurs or if you experience headache, confusion, or nausea.
- Contre-indications
Do not drive or use machinery for 5 hours after taking melatonin. Do not use this product if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80105370
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.